Status:
COMPLETED
The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
COVID19
Acute Renal Failure
Eligibility:
All Genders
Brief Summary
Aim of the study is to determinate the frequency of acute renal failure in COVID-19 patients, its relationship with the severity of COVID-19 disease in ICU, and the ability to take precautions against...
Eligibility Criteria
Inclusion
- Patients hospitalized in the intensive care unit diagnosed with COVID-19 will include in the study.
Exclusion
- there is no exclusion criteria
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT04799600
Start Date
September 1 2020
End Date
July 1 2021
Last Update
July 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara City Hospital
Ankara, Turkey (Türkiye), 06800